Published in J Urol on November 01, 2006
Thermal Ablation of Renal Tumors: Indications, Techniques and Results. Dtsch Arztebl Int (2015) 1.19
Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate. J Urol (2006) 1.40
Percutaneous computerized tomography guided cryoablation for localized renal cell carcinoma: factors influencing success. J Urol (2006) 1.03
Nicotinamide adenine dinucleotide staining immediately following radio frequency ablation of renal tumors-is a positive stain synonymous with ablative failure? J Urol (2006) 0.98
Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin Cancer Res (2003) 2.11
Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence. Clin Cancer Res (2004) 1.49
Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas. Hum Pathol (2007) 1.23
Prognostic significance of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol (2005) 1.15
Role of prostate biopsy schemes in accurate prediction of Gleason scores. Urology (2006) 1.12
Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer. Mod Pathol (2003) 0.97
Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas. Hum Pathol (2005) 0.89
Prognostic factors in prostate cancer. Am J Clin Pathol (2003) 0.85
Tissue-marking scheme for a cost-effective extended prostate biopsy protocol. Urol Oncol (2008) 0.84
Survivin and Bcl-2 expression in prostatic adenocarcinomas. Arch Pathol Lab Med (2004) 0.82
Neural network using combined urine nuclear matrix protein-22, monocyte chemoattractant protein-1 and urinary intercellular adhesion molecule-1 to detect bladder cancer. J Urol (2003) 0.80
Prognostic markers in prostate cancer. Expert Rev Mol Diagn (2002) 0.78
Bladder cancer: in search of the right operation for the right patient. J Urol (2006) 0.75
PSA-related markers in the detection of prostate cancer and high-grade disease in the contemporary era with extended biopsy. Urol Oncol (2007) 0.75